Combining multi-omics and drug perturbation profiles to identify novel treatments that improve disease phenotypes in spinal muscular atrophy
Meijboom, K. E.; Volpato, V.; Monzon-Sandoval, J.; Hoolachan, J. M.; Hammond, S. M.; Abendroth, F.; de Jong, O. G.; Hazell, G.; Ahlskog, N.; Wood, M. J.; Webber, C.; Bowerman, M.
Show abstract
Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by loss of survival motor neuron (SMN) protein. While SMN restoration therapies are beneficial, they are not a cure. We aimed to identify novel treatments to alleviate muscle pathology combining transcriptomics, proteomics and perturbational datasets. This revealed potential drug candidates for repurposing in SMA. One of the lead candidates, harmine, was further investigated in cell and animal models, improving multiple disease phenotypes, including SMN expression and lifespan. Our work highlights the potential of multiple, parallel data driven approaches for development of novel treatments for use in combination with SMN restoration therapies.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- DiPRO1 dependent transcriptional and epigenetic regulation distinctly controls the fate of muscle and mesenchymal cancer cells. 93%
- Clinical relevance of zebrafish for gene variants testing. Proof-of-principle with SMN1/SMA. 93%
- Lowering mutant huntingtin by small molecules relieves Huntington's disease symptoms and progression 93%
Similar papers in this journal
- Muscle cells of sporadic ALS patients secrete neurotoxic vesicles 95%
- Integrated data from R405W desmin knock-in mice highlight alterations of mitochondrial function, protein quality control, and myofibrillar structure in the initial stages of myofibrillar myopathy 94%
- Cell autonomous requirement of Neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis 94%
Similar papers in this journal
- Impact of liver-specific survival motor neuron (SMN) depletion on central nervous system and peripheral tissue pathology 95%
- EphrinB2 knockdown in cervical spinal cord preserves diaphragm innervation in a mutant SOD1 mouse model of ALS 94%
- Improvement of muscle strength in a mouse model for congenital myopathy treated with HDAC and DNA methyltransferase inhibitors 94%
Similar papers in this journal
- Chemical inhibition of SUMOylation activates the FSHD locus 94%
- Ascending dorsal column sensory neurons respond to spinal cord injury and downregulate genes related to lipid metabolism 94%
- Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.